Ovarian Cancer Surgery — Heed This LION’s Roar
Most women with ovarian cancer will have metastatic disease at diagnosis, and their symptoms and survival will depend on whether their abdominal tumor can be controlled. Death from ovarian cancer most often occurs from progression of abdominal disease, as a result of either bowel obstruction or the...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2019-02, Vol.380 (9), p.871-873 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 873 |
---|---|
container_issue | 9 |
container_start_page | 871 |
container_title | The New England journal of medicine |
container_volume | 380 |
creator | Eisenhauer, Eric L Chi, Dennis S |
description | Most women with ovarian cancer will have metastatic disease at diagnosis, and their symptoms and survival will depend on whether their abdominal tumor can be controlled. Death from ovarian cancer most often occurs from progression of abdominal disease, as a result of either bowel obstruction or the consequences of malnutrition. Removal of all visible disease is the goal of primary cytoreduction and is consistently associated with improved survival in randomized trials.
1
The nonvisible, microscopic tumor that remains is targeted with subsequent chemotherapy. Pelvic and aortic lymph nodes that appear normal frequently harbor microscopic metastases. For several decades, considerable debate has . . . |
doi_str_mv | 10.1056/NEJMe1900044 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2187026900</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2186817780</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-5e05b7872e684868b753f2da6637ad735da11c8ed1a80974867e5520b6517c4f3</originalsourceid><addsrcrecordid>eNpt0M1Kw0AUBeBBFFurO9cS0IULo3cyv1lKqbZSLWhdh0lyoylNUmcaobs-hBtfr09iSquIuLqbj8O5h5BjCpcUhLx66N3dIw0BgPMd0qaCMZ9zkLukDRBon6uQtciBc5OGAOXhPmkx0JSGVLRJMHo3Njel1zVlgtZ7qu0L2oW3Wn54fcTUG7_mzhsORg-r5afzHitjD8leZqYOj7a3Q55veuNu3x-Obgfd66GfMK7nvkAQsdIqQKm5ljpWgmVBaqRkyqSKidRQmmhMqdEQqoYoFCKAWAqqEp6xDjnf5M5s9Vajm0dF7hKcTk2JVe2igGoFgWw-b-jpHzqpals27dZKaqqUXquLjUps5ZzFLJrZvDB2EVGI1ltGv7ds-Mk2tI4LTH_w93gNONuAonBRiZPi_5wvDLd2rw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2186817780</pqid></control><display><type>article</type><title>Ovarian Cancer Surgery — Heed This LION’s Roar</title><source>EZB-FREE-00999 freely available EZB journals</source><source>New England Journal of Medicine</source><creator>Eisenhauer, Eric L ; Chi, Dennis S</creator><creatorcontrib>Eisenhauer, Eric L ; Chi, Dennis S</creatorcontrib><description>Most women with ovarian cancer will have metastatic disease at diagnosis, and their symptoms and survival will depend on whether their abdominal tumor can be controlled. Death from ovarian cancer most often occurs from progression of abdominal disease, as a result of either bowel obstruction or the consequences of malnutrition. Removal of all visible disease is the goal of primary cytoreduction and is consistently associated with improved survival in randomized trials.
1
The nonvisible, microscopic tumor that remains is targeted with subsequent chemotherapy. Pelvic and aortic lymph nodes that appear normal frequently harbor microscopic metastases. For several decades, considerable debate has . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMe1900044</identifier><identifier>PMID: 30811915</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Abdominal diseases ; Aorta ; Chemotherapy ; Intestine ; Lymph nodes ; Lymphatic system ; Malnutrition ; Medical prognosis ; Metastases ; Ovarian cancer ; Surgery ; Survival ; Womens health</subject><ispartof>The New England journal of medicine, 2019-02, Vol.380 (9), p.871-873</ispartof><rights>Copyright © 2019 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c348t-5e05b7872e684868b753f2da6637ad735da11c8ed1a80974867e5520b6517c4f3</citedby><cites>FETCH-LOGICAL-c348t-5e05b7872e684868b753f2da6637ad735da11c8ed1a80974867e5520b6517c4f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMe1900044$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMe1900044$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30811915$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eisenhauer, Eric L</creatorcontrib><creatorcontrib>Chi, Dennis S</creatorcontrib><title>Ovarian Cancer Surgery — Heed This LION’s Roar</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Most women with ovarian cancer will have metastatic disease at diagnosis, and their symptoms and survival will depend on whether their abdominal tumor can be controlled. Death from ovarian cancer most often occurs from progression of abdominal disease, as a result of either bowel obstruction or the consequences of malnutrition. Removal of all visible disease is the goal of primary cytoreduction and is consistently associated with improved survival in randomized trials.
1
The nonvisible, microscopic tumor that remains is targeted with subsequent chemotherapy. Pelvic and aortic lymph nodes that appear normal frequently harbor microscopic metastases. For several decades, considerable debate has . . .</description><subject>Abdominal diseases</subject><subject>Aorta</subject><subject>Chemotherapy</subject><subject>Intestine</subject><subject>Lymph nodes</subject><subject>Lymphatic system</subject><subject>Malnutrition</subject><subject>Medical prognosis</subject><subject>Metastases</subject><subject>Ovarian cancer</subject><subject>Surgery</subject><subject>Survival</subject><subject>Womens health</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0M1Kw0AUBeBBFFurO9cS0IULo3cyv1lKqbZSLWhdh0lyoylNUmcaobs-hBtfr09iSquIuLqbj8O5h5BjCpcUhLx66N3dIw0BgPMd0qaCMZ9zkLukDRBon6uQtciBc5OGAOXhPmkx0JSGVLRJMHo3Njel1zVlgtZ7qu0L2oW3Wn54fcTUG7_mzhsORg-r5afzHitjD8leZqYOj7a3Q55veuNu3x-Obgfd66GfMK7nvkAQsdIqQKm5ljpWgmVBaqRkyqSKidRQmmhMqdEQqoYoFCKAWAqqEp6xDjnf5M5s9Vajm0dF7hKcTk2JVe2igGoFgWw-b-jpHzqpals27dZKaqqUXquLjUps5ZzFLJrZvDB2EVGI1ltGv7ds-Mk2tI4LTH_w93gNONuAonBRiZPi_5wvDLd2rw</recordid><startdate>20190228</startdate><enddate>20190228</enddate><creator>Eisenhauer, Eric L</creator><creator>Chi, Dennis S</creator><general>Massachusetts Medical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20190228</creationdate><title>Ovarian Cancer Surgery — Heed This LION’s Roar</title><author>Eisenhauer, Eric L ; Chi, Dennis S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-5e05b7872e684868b753f2da6637ad735da11c8ed1a80974867e5520b6517c4f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Abdominal diseases</topic><topic>Aorta</topic><topic>Chemotherapy</topic><topic>Intestine</topic><topic>Lymph nodes</topic><topic>Lymphatic system</topic><topic>Malnutrition</topic><topic>Medical prognosis</topic><topic>Metastases</topic><topic>Ovarian cancer</topic><topic>Surgery</topic><topic>Survival</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eisenhauer, Eric L</creatorcontrib><creatorcontrib>Chi, Dennis S</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eisenhauer, Eric L</au><au>Chi, Dennis S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ovarian Cancer Surgery — Heed This LION’s Roar</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2019-02-28</date><risdate>2019</risdate><volume>380</volume><issue>9</issue><spage>871</spage><epage>873</epage><pages>871-873</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>Most women with ovarian cancer will have metastatic disease at diagnosis, and their symptoms and survival will depend on whether their abdominal tumor can be controlled. Death from ovarian cancer most often occurs from progression of abdominal disease, as a result of either bowel obstruction or the consequences of malnutrition. Removal of all visible disease is the goal of primary cytoreduction and is consistently associated with improved survival in randomized trials.
1
The nonvisible, microscopic tumor that remains is targeted with subsequent chemotherapy. Pelvic and aortic lymph nodes that appear normal frequently harbor microscopic metastases. For several decades, considerable debate has . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>30811915</pmid><doi>10.1056/NEJMe1900044</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-4793 |
ispartof | The New England journal of medicine, 2019-02, Vol.380 (9), p.871-873 |
issn | 0028-4793 1533-4406 |
language | eng |
recordid | cdi_proquest_miscellaneous_2187026900 |
source | EZB-FREE-00999 freely available EZB journals; New England Journal of Medicine |
subjects | Abdominal diseases Aorta Chemotherapy Intestine Lymph nodes Lymphatic system Malnutrition Medical prognosis Metastases Ovarian cancer Surgery Survival Womens health |
title | Ovarian Cancer Surgery — Heed This LION’s Roar |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T18%3A00%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ovarian%20Cancer%20Surgery%20%E2%80%94%20Heed%20This%20LION%E2%80%99s%20Roar&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Eisenhauer,%20Eric%20L&rft.date=2019-02-28&rft.volume=380&rft.issue=9&rft.spage=871&rft.epage=873&rft.pages=871-873&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMe1900044&rft_dat=%3Cproquest_cross%3E2186817780%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2186817780&rft_id=info:pmid/30811915&rfr_iscdi=true |